-
公开(公告)号:EP0940391A3
公开(公告)日:1999-11-10
申请号:EP98204483.6
申请日:1995-05-23
IPC分类号: C07D215/52 , A61K31/47 , C07D409/04 , C07D405/04 , C07D401/04 , C07D409/12 , C07D221/18 , C07D417/04 , C07D401/12 , C07D405/12
CPC分类号: C04B35/632 , A61K31/00 , A61K31/4709 , C07D215/52 , C07D221/18 , C07D401/04 , C07D401/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D417/04
摘要: NK 3 receptor antagonists of formula (I):
are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.-
公开(公告)号:EP0940391A2
公开(公告)日:1999-09-08
申请号:EP98204483.6
申请日:1995-05-23
IPC分类号: C07D215/52 , A61K31/47 , C07D409/04 , C07D405/04 , C07D401/04 , C07D409/12 , C07D221/18 , C07D417/04 , C07D401/12 , C07D405/12
CPC分类号: C04B35/632 , A61K31/00 , A61K31/4709 , C07D215/52 , C07D221/18 , C07D401/04 , C07D401/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D417/04
摘要: NK 3 receptor antagonists of formula (I):
are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.摘要翻译: 式(I)的NK3受体拮抗剂:特别用于治疗肺病症,CNS病症和神经变性病症。
-